deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT03219372

Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence

Sponsor: Cedars-Sinai Medical Center

Conditions Hepatocellular Carcinoma Liver Cirrhoses
Interventions Placebo Oral Tablet Pravastatin Pill
Updated 14 times since 2017 Last updated: Dec 31, 2020 Started: Sep 27, 2018 Primary completion: Dec 4, 2018 Completion: Mar 5, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study discontinued due to low accrual.

Other terminated trials from Cedars-Sinai Medical Center

See all terminations from Cedars-Sinai Medical Center

Other Hepatocellular Carcinoma trials with similar outcome

Browse all Hepatocellular Carcinoma trials

This PHASE2 trial investigates Hepatocellular Carcinoma and Liver Cirrhoses and is currently terminated or withdrawn. Cedars-Sinai Medical Center leads this study, which shows 14 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Aug 2017 – ~Dec 2017 · 4 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Nov 2018 · 3 months · monthly snapshot~Nov 2018 – ~Mar 2019 · 4 months · monthly snapshot~Mar 2019 – ~Jul 2019 · 4 months · monthly snapshot~Jul 2019 – ~Jun 2020 · 11 months · monthly snapshot~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Dec 2021 · 10 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Feb 2021 — Dec 2021 [monthly]

    Terminated PHASE2

    Status: Recruiting → Terminated

  5. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE2

▶ Show 9 earlier versions

  1. Jun 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  2. Jul 2019 — Jun 2020 [monthly]

    Recruiting PHASE2

  3. Mar 2019 — Jul 2019 [monthly]

    Recruiting PHASE2

  4. Nov 2018 — Mar 2019 [monthly]

    Recruiting PHASE2

  5. Aug 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  6. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  7. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting PHASE2

  8. Dec 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE2

    Status: Recruiting → Not Yet Recruiting

  9. Aug 2017 — Dec 2017 [monthly]

    Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cedars-Sinai Medical Center
  • National Cancer Institute (NCI)
  • National Institutes of Health (NIH)
Data source: Cedars-Sinai Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations